↓ Skip to main content

Dose response of umeclidinium administered once or twice daily in patients with COPD: a randomised cross-over study

Overview of attention for article published in BMC Pulmonary Medicine, January 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

blogs
1 blog
policy
1 policy source
twitter
2 X users

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
55 Mendeley
Title
Dose response of umeclidinium administered once or twice daily in patients with COPD: a randomised cross-over study
Published in
BMC Pulmonary Medicine, January 2014
DOI 10.1186/1471-2466-14-2
Pubmed ID
Authors

Alison Church, Misba Beerahee, Jean Brooks, Rashmi Mehta, Palvi Shah

Abstract

Umeclidinium bromide (UMEC) is an inhaled long-acting muscarinic antagonist in development for chronic obstructive pulmonary disease (COPD).

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
Unknown 54 98%

Demographic breakdown

Readers by professional status Count As %
Other 12 22%
Researcher 8 15%
Student > Bachelor 6 11%
Student > Ph. D. Student 6 11%
Student > Master 4 7%
Other 6 11%
Unknown 13 24%
Readers by discipline Count As %
Medicine and Dentistry 23 42%
Pharmacology, Toxicology and Pharmaceutical Science 4 7%
Agricultural and Biological Sciences 4 7%
Biochemistry, Genetics and Molecular Biology 3 5%
Social Sciences 3 5%
Other 5 9%
Unknown 13 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 January 2015.
All research outputs
#2,936,936
of 23,881,329 outputs
Outputs from BMC Pulmonary Medicine
#193
of 2,030 outputs
Outputs of similar age
#34,690
of 310,753 outputs
Outputs of similar age from BMC Pulmonary Medicine
#4
of 20 outputs
Altmetric has tracked 23,881,329 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,030 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 310,753 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.